Optimal two-stage designs for phase II clinical trialsRichard Simon(National Cancer Institute)Controlled Clinical TrialsMarch 1, 198910.1016/0197-2456(89)90015-9Cited by 3,635SaveCiteExport RISWatch citationsAbstractRelated PapersA Multiple Testing Procedure for Clinical TrialsPeter C. O’Brien, Thomas R. Fleming|Biometrics|1979|3.3kOne-Sample Multiple Testing Procedure for Phase II Clinical TrialsThomas R. Fleming|Biometrics|1982|997The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentEdmund A. Gehan|Journal of Chronic Diseases|1961|670Biopharmaceutical Statistics for Drug Development.Kathleen R. Lamborn, Karl E. Peace|Journal of the American Statistical Association|1989|302Predictive Probability Early Termination Plans For Phase II Clinical TrialsJay Herson|Biometrics|1979|142